Synopsys, Inc. (SNPS) Shares Suffer Worst Day Ever Amid Q325 Results Revealing Problems With Major Foundry Customer -- Hagens Berman
Synopsys, Inc. (SNPS) Shares Suffer Worst Day Ever Amid Q325 Results Revealing Problems With Major Foundry Customer -- Hagens Berman
SAN FRANCISCO--(BUSINESS WIRE)--On September 10, 2025, investors in Synopsys, Inc. (NASDAQ: SNPS) saw the price of their shares crater over $216 (-36%) after the company reported its Q3 2025 financial results and revealed significant problems with a major foundry customer.
The development has prompted national shareholders rights firm Hagens Berman to open an investigation into whether Synopsys may have misled investors about its customer risks and growth prospects.
The firm urges investors in Synopsys who suffered significant losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys.
Visit: |
||
Contact the Firm Now: |
||
|
844-916-0895 |
Synopsys, Inc. (SNPS) Investigation:
In the past Synopsys has assured investors that, while its largest customer (Intel) had reduced its R&D spend, “it does not impact generally the EDA software[]” and downplayed risks based on its “committed, non-cancellable” agreements with Intel involving a mix of EDA software, IP, and hardware.
The company’s assurances may have come into question on September 9, 2025, when Synopsys reported its Q3 2025 financial results and shockingly guided for Q4 2025 GAAP EPS of negative $0.27 to negative $0.16.
During the earnings call, management revealed the company’s underperformance in its IP business and said it was significantly due to “challenges at a major foundry customer” that is “also having a sizeable impact on the year[.]”
This news drove the price of Synopsys shares down 36% the next day, its worst-ever single-day percentage decline since going public in 1992.
“We’re investigating whether Synopsys may have misled investors about risks posed by its high concentration with a single customer,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Synopsys and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »
If you’d like more information and answers to frequently asked questions about the Synopsys investigation, read more »
Whistleblowers: Persons with non-public information regarding Synopsys should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email SNPS@hbsslaw.com.
Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
Contacts
Reed Kathrein, 844-916-0895
